Belén Dávila

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

Universidad de la República de Uruguay(Current)

Institut de Ciència de Materials de Barcelona

Institut Pasteur de Montevideo

Technion – Israel Institute of Technology

Belén Dávila is an author at Universidad de la República de Uruguay specializing in drug discovery, glioblastoma drug therapy, and cancer pharmacology.

Publications per year

2015–2023

Publications

Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity

Catalina Alamón, Belén Dávila, María Fernanda García et al. · Cancers · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17

A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma: <i>In Vitro</i> and <i>in Vivo</i> Exploration

Catalina Alamón, Belén Dávila, María Fernanda García et al. · Molecular Pharmaceutics · 2023 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

Carboranylanilinoquinazoline EGFR-Inhibitors: Toward ‘Lead-to-Candidate’ Stage in the Drug-Development Pipeline

Marcos Couto, Catalina Alamón, Carina Sánchez et al. · Future Medicinal Chemistry · 2019 · 23 citations · Full text

Medicine, Medicinal Chemistry, Oncology +17

3-H-[1,2]Dithiole as a New Anti-Trypanosoma cruzi Chemotype: Biological and Mechanism of Action Studies

Marcos Couto, Carina Sánchez, Belén Dávila et al. · Molecules · 2015 · 13 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–4 of 4